Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The membrane phospholipid fatty acid incorporation site refers to the biochemical position within cellular membrane phospholipids, typically the sn-2 position of the glycerol backbone, where fatty acids are esterified during the remodeling process known as the Lands' cycle. This site is the primary point of entry for polyunsaturated fatty acids (PUFAs) like arachidonic acid and eicosapentaenoic acid (EPA) into the membrane bilayer, a process catalyzed by various lysophospholipid acyltransferases (LPLATs) such as LPCAT3 and MBOAT7. The incorporation of specific fatty acids at this site is a critical determinant of membrane biophysical properties, including fluidity and permeability, and serves as a regulatory reservoir for bioactive lipid signaling molecules. Pharmacologically, this site is the functional target for omega-3 fatty acid supplements, which compete with pro-inflammatory arachidonic acid for incorporation, thereby modulating the cellular inflammatory response and cardiovascular health.
Competitive incorporation into the sn-2 position of phospholipids to displace arachidonic acid and reduce pro-inflammatory eicosanoid precursors.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane phospholipid fatty acid incorporation site.